Premium Industrial News

Sanofi Offers Facilities to Rivals for COVID-19 Vaccines

Sanofi Offers Facilities to Rivals for COVID-19 Vaccines

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 204 Words
Attachment: COVID vaccine 0521

SUGAR LAND--May 4, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Sanofi is offering manufacturing space to its rival vaccine manufacturers for the production of all three approved COVID-19 vaccines. It is the only major drug company to be involved in the production of all three.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?